Laser and Plasma-Based Therapies for Skin Conditions and Cosmetic Procedures
This research community focuses on the clinical application of energy-based devices, specifically lasers and plasma systems, to treat dermatological conditions and perform cosmetic procedures. The work centers on evaluating the efficacy and safety of these interventions for skin rejuvenation, scar revision, and the management of inflammatory skin disorders.
The literature is dominated by studies on fractional carbon dioxide (CO2) lasers, neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers, and argon plasma coagulation. Recurring applications include the treatment of acne scars, vitiligo, and hidradenitis suppurativa, alongside cosmetic procedures involving hyaluronic acid and calcium hydroxylapatite fillers. A significant portion of the output consists of randomized controlled trials, systematic reviews, and meta-analyses comparing different laser modalities, such as excimer lasers versus other light sources, or fractional CO2 versus ablative techniques. The research frequently addresses combined treatment strategies and the management of adverse effects, with specific attention to patient outcomes in diverse skin types.
The largest share of the community's output is found in Argon research, accounting for 4.8% of all Argon-related papers, followed by Yttrium at 2.9% and Erbium at 2.9%. Argon also contributes the highest number of papers to this group, with 1,652 entries.
The community comprises 15,462 papers, primarily published in Dermatologic Therapy, Dermatologic Surgery, and the Journal of Cosmetic and Laser Therapy.
Recent work continues to focus on optimizing laser protocols for scar treatment and evaluating the safety of cosmetic fillers, with specific attention to the use of fractional CO2 lasers for exosome delivery and the management of keloids and hypertrophic scarring.